UBS raised the firm’s price target on Gentex (GNTX) to $28 from $23 and keeps a Neutral rating on the shares. The firm walked away from the Q2 earnings report more positive, with gross margin upside and the profitability profile of VOXX not being as bad as feared, but thinks consensus 2026 numbers may move up mid to high single digits and second half gross margins should step down, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GNTX: